Long-term outcome in PCNSL patients treated with high-dose methotrexate and deferred radiation.
Gerstner
Elizabeth R
ER
Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA.
Carson
Kathryn A
KA
Grossman
Stuart A
SA
Batchelor
Tracy T
TT
D000328:Adult; D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage*; D001932:Brain Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy*; D018450:Disease Progression; D018572:Disease-Free Survival; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D006801:Humans; D053208:Kaplan-Meier Estimate; D008223:Lymphoma / Q000188:drug therapy* / Q000532:radiotherapy*; D008727:Methotrexate / Q000008:administration & dosage*; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy / Q000532:radiotherapy; D011878:Radiotherapy / Q000379:methods*; D015996:Survival Rate; D013995:Time; D016896:Treatment Outcome
D000964:Antimetabolites, Antineoplastic; D008727:Methotrexate